T his is an interesting paper aiming to review the history of osteonecrosis of the jaw and the terminology that has been largely adopted in the scientific literature to define and classify the disease since its first description more than 15 years ago. It's the author Currently the disease burden is still underestimated and the epidemiological data reported in the literature are likely to be unrealistic, especially in clinical trials and epidemiological studies where the AAOMS definition has been uniquely adopted by the adjudication Commitees. [1] T here is a clear need to rephrase the AAOMS definition of Medication-related osteonecrosis of the jaw (MRONJ) not just to include all possible clinical manifestations, but also to discard the 8-weeks observation period that is actually requested to confirm the clinical suspicion of MRONJ.
In an attempt to overcome these obstacoles and anticipate diagnosis and treatment, the Expert Panel of the Italian Society for Maxillofacial Surgery (SICMF) and the Italian Society of Oral Pathology and Medicine (SIPMO) published in 2012 [2] a distinct definition of bisphosphonate-related osteonecrosis of the jaw (BRONJ) that has not been included in the present review. T his definition was recently upgraded to include also medications other than bisphosphonates. [3] Fostering a definition as such has the advantage of anticipating both diagnosis and treatment of patients, but it requires the adoption of a diagnostic work-up that relies not only on clinical signs and symtoms, but also on radiological signs of osteonecrosis [4] [5] [6] . In fact, both clinical and radiological signs of osteonecrosis are non specific and have to be mutually implemented in the diagnostic process to level the risk of misdiagnosis. [2] 
